Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on L 1. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115385916B reveals high-yield chiral synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing globally.
Patent CN112209947A details a mild, high-yield synthesis of chiral indoxazinones with potent anti-tumor activity, offering scalable solutions for reliable pharmaceutical intermediate suppliers.
Novel copper-catalyzed one-step synthesis of 3,4-cyclopentyl-1-tetralone. Reduces steps, improves yield, ensures supply chain reliability for pharmaceutical intermediate manufacturing.
Novel chiral phosphoric acid catalysis enables high-yield antitumor intermediate production with reduced costs and enhanced supply chain reliability for global pharmaceutical partners.
Novel palladium-catalyzed carbonylation route for high-purity quinolone intermediates. Reduces cost and enhances supply chain reliability for pharmaceutical manufacturing.
Patent CN113880781B reveals glucose-based route for triazoles. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN113105402B reveals a metal-free iodine-promoted synthesis for 3,4,5-trisubstituted 1,2,4-triazoles, offering significant cost reduction in API manufacturing and scalable production.
Novel palladium-catalyzed carbonylation method for indole-3-formamide. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Patent CN108794412B details a high-yield base-promoted cyclization for triazoles, offering significant cost reduction in API manufacturing and superior purity profiles.
Patent CN114920707B reveals a novel iodine-promoted route using DMF as a carbon source for high-purity triazole intermediates, offering significant cost and supply chain advantages.
Patent CN114195711B reveals a novel Pd-catalyzed carbonylation route for quinoline-4(1H)-one. This method offers significant supply chain reliability and cost reduction in pharmaceutical intermediate manufacturing.
Novel visible-light catalytic ruthenium complex enables efficient alkyne-aldehyde addition. Reduces energy costs and simplifies purification for pharmaceutical intermediate manufacturing.
Novel Te/I catalyzed one-step synthesis of 2-trifluoromethyl oxazoles. High purity pharma intermediates with reduced steps and cost-effective manufacturing.
Efficient Mn-catalyzed cyclization method for complex heterocycles. High yield, green chemistry, scalable production for pharma intermediates.
Novel metal-free route for trifluoromethyl pyrazoles. Reduces cost and improves supply chain reliability for pharma intermediates. Efficient room temperature reaction.
Patent CN106831474B details a rhodium-catalyzed synthesis of alpha-aryl-alpha,beta-diamino acid esters with high selectivity for anticancer drug manufacturing.
Patent CN114920707B reveals a novel DMF-based synthesis for 3-trifluoromethyl-1,2,4-triazoles, offering significant cost reduction in API manufacturing and simplified supply chains.
Novel Pd-catalyzed carbonylation route for 2-CF3 quinazolinones using solid CO sources. Enhances purity and safety for API manufacturing supply chains.
Patent CN108774263A reveals a metal-free synthesis route for allyl phosphine oxides. This method offers significant supply chain stability and cost advantages for pharmaceutical intermediate manufacturing.
Novel metal-free visible light catalytic method for 1,2,3,4-tetrahydronaphthalene intermediates. Offers high atom utilization and mild conditions for pharma manufacturing.